Clinical Research Organization Quartesian Signs Global Medical Technology Company

Quartesian, a multinational Clinical Research Organization (CRO), serves the biopharmaceutical and medical device industry. Today, it announced a multi-year agreement with a leading portfolio medical technology company. Under the agreement, Quartesian is providing Electronic Data Capture programming using Medidata Rave EDC, SAS statistical services, and full data management.

The company specializes in high-quality clinical data at affordable prices. The client’s processes and systems are updated with modern EDC technology. They needed to partner with someone who had the expertise and broad experience with Medidata’s EDC platform. It collaborated with the transition from multiple legacy processes and standardize their clinical data architecture to speed up the analysis and improve the data quality.

The company spokesperson said, “Quartesian was able to bridge the gap between our previous processes and a digital environment and their data management team helped develop our global EDC library standards. As an industry leader in providing clean data faster, Quartesian was the ideal choice.”Steve Boccardo, VP of Business Development, and Commercial Strategy for Quartesian said that an industry leader, the customer looked for a domain expert to help them with this task. The flexible global footprint provides the expertise, efficiency, and innovation to maintain their success.

Clinical Research Organization and Sponsors alike value the Quartesian solutions to help them Take Back Control of their data. The company leverages industry-leading technologies paired with deep clinical trial expertise to help clients bring treatments faster and efficiently. Quartesian is the Clinical Data Company that provides insightful data to clinical studies performing organizations.